Lapahope is a prescription medication used to treat certain types of breast cancer, including HER2-positive breast cancer.
Composition:
Each tablet of Lapahope contains 250mg of lapatinib.
Mechanism of Action:
Lapatinib works by:
- Inhibiting the activity of HER2, a protein that can help cancer cells grow and multiply
- Reducing the levels of HER2 in the body, which can help slow or stop the growth of cancer cells
Uses:
Lapahope is used to treat:
- Advanced HER2-positive breast cancer (cancer that has spread to other parts of the body)
- Breast cancer that has not responded to other treatments
- Breast cancer that has recurred after other treatments
Dosage:
The recommended dosage of Lapahope is:
- 250mg taken orally twice daily, with food
Side Effects:
Common side effects of Lapahope include:
- Diarrhea
- Fatigue
- Nausea and vomiting
- Headache
- Abdominal pain
- Skin rash
- Increased risk of blood clots
- Increased risk of liver damage
Recommendation:
Lapahope is recommended for patients with advanced HER2-positive breast cancer who have not responded to other treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.
Important Note:
Patients should not take Lapahope if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking Lapahope.
Some common brands of lapatinib include:
- Tykerb (GlaxoSmithKline)
- Tyverb (GlaxoSmithKline)
Please note that Lapahope is not available in all markets and may be approved for different indications and dosages in different regions.
Reviews
There are no reviews yet.